Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1970 Jul;2(1):11–14. doi: 10.1128/iai.2.1.11-14.1970

Decreased Growth Capacity of Passaged Gross Virus-Induced Mouse Lymphomas After Incubation with Antithymocytic Sera

Donna L Vredevoe 1, Esther F Hays 2
PMCID: PMC415956  PMID: 16557788

Abstract

AKR or C3H/HeJ transplanted mouse lymphomas, originally induced by Gross virus, could be neutralized by in vitro incubation with an immunosuppressive rabbit anti-mouse thymus cell serum. Neutralization was measured by significantly increased latent periods or decreased incidence (at a minimum of 90 days post-transfer) of lymphoma in syngeneic recipients of lymphoma cells incubated with antithymocytic serum when compared with syngeneic recipients of lymphoma cells incubated with normal rabbit serum.

Full text

PDF
11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos B. Some reactions of cytotoxic antibodies against previously unknown mouse isoantigens. Ann N Y Acad Sci. 1965 Jun 30;124(1):61–72. doi: 10.1111/j.1749-6632.1965.tb18943.x. [DOI] [PubMed] [Google Scholar]
  2. Bremberg S., Klein E., Stjernswärd J. Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis. Cancer Res. 1967 Nov;27(11):2113–2118. [PubMed] [Google Scholar]
  3. GORER P. A. Some recent work on tumor immunity. Adv Cancer Res. 1956;4:149–186. doi: 10.1016/s0065-230x(08)60724-1. [DOI] [PubMed] [Google Scholar]
  4. HELLSTROM K. E. Cytotoxic effect of isoantibodies on mouse tumor cells in vitro. Transplant Bull. 1959 Apr;6(2):411–416. [PubMed] [Google Scholar]
  5. James K. Anti-lymphocytic antibody--a review. Clin Exp Immunol. 1967 Nov;2(6):615–631. [PMC free article] [PubMed] [Google Scholar]
  6. MOHOS S. C., KIDD J. G. Effects of various immune rabbit serums on the cells of several transplanted mouse lymphomas in vitro and in vivo; with special reference to inhibition by an antibody that reacts with neoplastic and non-neoplastic lymphocytic cells of mice. J Exp Med. 1957 Mar 1;105(3):233–263. doi: 10.1084/jem.105.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MOLLER G. Studies on the mechanism of immunological enhancement of tumor homografts. II. Effect of isoantibodies on various tumor cells. J Natl Cancer Inst. 1963 Jun;30:1177–1203. [PubMed] [Google Scholar]
  8. Silver R. T. The treatment of chronic lymphocytic leukemia. Semin Hematol. 1969 Oct;6(4):344–356. [PubMed] [Google Scholar]
  9. Starzl T. E., Brettschneider L., Penn I., Schmidt R. W., Bell P., Kashiwagi N., Townsend C. M., Putnam C. W. A trial with heterologous antilymphocyte globulin in man. Transplant Proc. 1969 Mar;1(1):448–454. [PMC free article] [PubMed] [Google Scholar]
  10. Vredevoe D. L., Hays E. F. Effect of antilymphocytic and antithymocytic sera on the development of mouse lymphoma. Cancer Res. 1969 Sep;29(9):1685–1690. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES